Clinical Trials Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Heart Disease
Acusphere, Inc. Reports Q2 2007 Financial Results and Operating Highlights
August 27th, 2007
Advancing other product development candidates The Company continues to focus on the steps necessary to submit an NDA for Imagify and support the MAA filing in Europe by Nycomed, its European partner. In addition to preparing the clinical sections of the NDA in electronic filing format, Acusphere is working to qualify its commercial manufacturing facility for Imagify, including aseptic validation, process performance qualification and continued product stability testing. The Company plans to complete these qualification steps in time to support a Q4 2007 NDA submission. In addition, the Company plans to announce a product development program later in the third quarter...
Source: Clinical Trials Week (2007-08-27)
|
